selected publications
-
academic article
- Engineered Human Cathelicidin Antimicrobial Peptides Inhibit Ebola Virus Infection.. iScience. 23:-. 2020
- Comparison of N- and O-linked glycosylation patterns of ebolavirus glycoproteins.. Virology. 502:39-47. 2017
- Staphylococcus Aureus: Current State of Prevalence, Impact, and Vaccine Development.. Current pharmaceutical design. :-. 2015
- Pharmaceutical screen identifies novel target processes for activation of autophagy with a broad translational potential.. Nature communications. 6:-. 2015
- Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names.. Viruses. 6:3663-3682. 2014
- Ebola virus-like particles stimulate type I interferons and proinflammatory cytokine expression through the toll-like receptor and interferon signaling pathways.. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research. 34:79-89. 2014
- Induced IL-10 splice altering approach to antiviral drug discovery.. Nucleic acid therapeutics. 24:179-185. 2014
- Autophagy as an immune effector against tuberculosis.. Current opinion in microbiology. 16:355-365. 2013
- Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae.. Archives of virology. 158:301-311. 2013
- Mouse models for filovirus infections.. Viruses. 4:1477-1508. 2012
- TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation.. Immunity. 37:223-234. 2012
- A STAT-1 knockout mouse model for Machupo virus pathogenesis.. Virology journal. 8:-. 2011
- Correlates of immunity to filovirus infection.. Viruses. 3:982-1000. 2011
- Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies.. Antiviral research. 90:85-92. 2011
- Development and characterization of rabbit and mouse antibodies against ebolavirus envelope glycoproteins.. Journal of virological methods. 174:99-109. 2011
- Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice.. Vaccine. 29:2968-2977. 2011
- Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.. Journal of virology. 85:8502-8513. 2011
- Filovirus infection of STAT-1 knockout mice.. The Journal of infectious diseases. 204 Suppl 3:S986-S990. 2011
- Filovirus vaccines.. Human vaccines. 7:701-711. 2011
- Mechanisms and consequences of ebolavirus-induced lymphocyte apoptosis.. Journal of immunology (Baltimore, Md. : 1950). 184:327-335. 2010
- Development and characterization of a mouse model for Marburg hemorrhagic fever.. Journal of virology. 83:6404-6415. 2009
- Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery. 2009
- Reduced expression of CD45 protein-tyrosine phosphatase provides protection against anthrax pathogenesis. 2009
- Reduced levels of protein tyrosine phosphatase CD45 protect mice from the lethal effects of Ebola virus infection.. Cell host & microbe. 6:162-173. 2009
- Functional CD8+ T cell responses in lethal Ebola virus infection.. Journal of immunology (Baltimore, Md. : 1950). 180:4058-4066. 2008
- Development of a model for marburgvirus based on severe-combined immunodeficiency mice.. Virology journal. 4:-. 2007
- Lymphocyte death in a mouse model of Ebola virus infection.. The Journal of infectious diseases. 196 Suppl 2:S296-S304. 2007
-
document
- Ambroxol and Ciprofloxacin Show Activity Against SARS-CoV2 in Vero E6 Cells at Clinically-Relevant Concentrations.. bioRxiv : the preprint server for biology. -. 2020